In this video, Dr. Upendra Kaul, Executive Director & Dean, Fortis Group of Hospitals, will talk that India's private sector or Government does not have a policy on venturing into the stent market in India. He says that things are changing rapidly. The first generations of the cardiovascular devices started from the west as they had the patents. Also, the research and development of such devices take lot of money. Stents in India came during 1989 ï¿½ 90. There is always a competition regarding good quality or parameters are compared. He further says that one third of the stents used in the country are from Indian market.
Dr. KK Aggarwal
President Heart Care Foundation of India and Group Editor in Chief MEDtalks
Dr. Prof Upendra Kaul
Chairman Batra Heart Centre and Dean Academics and Research of BHMRC, New Delhi.